Cutamesine

DB06618InvestigationalSmall molecule

Investigated for use/treatment in strokes and depression.

Chemical structure of Cutamesine
Primary indication
Investigated for use/treatment in strokes and depression.Curator reviewed
Formula / weight
C23H32N2O2 · 368.521 g/mol (avg)
Code names
SA-4503

Resolves to

Compound
UNII9J7A4144BXCAS165377-43-5ChEMBLCHEMBL408867
Structure
InChIKeyUVSWWUWQVAQPJR-UHFFFAOYSA-NSMILESCOC1=C(OC)C=C(CCN2CCN(CCCC3=CC=CC=C3)CC2)C=C1
Targets
Q99720SIGMAR1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cutamesine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In